This article was originally published in The Tan Sheet
Receives FDA warning letter Aug. 19 stating that its Fine or Oily Hair Dandruff Shampoo and Good Sense Dandruff Shampoo do not comply with labeling requirements in the final monograph for OTC dandruff, seborrheic dermatitis and psoriasis products. Specifically, Perrigo's Fine or Oily Dandruff Shampoo does not carry the required "directions for use" statement, and neither dandruff product carries the required warning to keep it out of the reach of children, FDA said. The warning letter arose from a Perrigo request in June to export the dandruff products to Mexico
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC